| Literature DB >> 35496885 |
J Sergio Durand-Niconoff1, Erik Ortiz-Blanco1, Gabriela Sosa-Ortiz2, José L Olivares-Romero3, Enrique Juárez-Aguilar4, Eva Luz Montoya-Hernández4, Cynthia Fernández-Pomares5, Ricardo Tovar-Miranda1, María Eugenia Castro6, Francisco J Melendez7, Tomás Guerrero1.
Abstract
The synthesis of six Mannich bases derived from hydroxycoumarins was carried out in moderate yields, two of these derivatives were described for the first time. Conformational analysis was performed through DFT theoretical calculations explaining the formation of stable six membered rings based on intramolecular hydrogen bonds within the structure. These findings were correlated with the antiproliferative activity. The biological activity of the Mannich bases through their antiproliferative activity in the HeLa cancer cell line is described for the first time, showing that the compounds were able to inhibit proliferation in cervical cancer by more than 60%. Likewise, the theoretical modeling of the photophysical properties was realized with promising results, showing that the HOMO-LUMO energies of the new compounds present the lowest electronic gap values for those with donor groups in their structure, which makes them potential fluorophores. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35496885 PMCID: PMC9041333 DOI: 10.1039/d1ra04611j
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Scheme 1Synthesis of Mannich derivatives of 7-hydroxy-4-methyl (4a) and 6,7-dihydroxy-4-methylcoumarins (4b).
Scheme 2Resonance structures explaining the electrophilic attack in 7-hydroxy-4-methylcoumarin.
Fig. 1Molecular structures of the conformers syn of compound 5a–5c through dihedral angle C8–C7–O7–H7.
Fig. 2Potential energy surfaces of the torsions of the hydroxyl groups at position 6 and 7 and molecular structures of the compounds 5d–5f through dihedral angles C5–C6–O6–H6 and C8–C7–O7–H7, respectively.
Molecular orbital energies (EHOMO and ELUMO, eV), gap energies (Eg, eV), total energy (ETot, hartrees), and relative energy (ΔERel, 104 kcal mol−1) of 4a, 4b and 5a–5f compounds calculated at PBE0/aug-cc-pVTZ level of theory
| Compound |
|
|
|
| Δ |
|---|---|---|---|---|---|
| 4a | −6.523 | −1.700 | 4.823 | −611.1178 | 22.90 |
| 5a | −6.317 | −1.633 | 4.683 | −900.8969 | 4.72 |
| 5b | −6.330 | −1.636 | 4.693 | −861.6120 | 7.18 |
| 5c | −6.333 | −1.640 | 4.694 | −862.8067 | 7.11 |
| 4b | −6.250 | −1.705 | 4.545 | −686.3014 | 18.18 |
| 5d | −6.078 | −1.629 | 4.449 | −976.0815 | 0.0 |
| 5e | −6.090 | −1.633 | 4.458 | −936.7966 | 2.47 |
| 5f | −6.087 | −1.635 | 4.452 | −937.9912 | 2.39 |
E g-reported = 4.154 eV.[29]
Fig. 3QTAIM structures of compounds 5a–5f. Green dots represent the bond critical points (BCPs), while cyan dots represent the ring critical points (RCPs).
Topological indexes of electronic density in critical points for selected bonds of compounds 5a–5f calculated at PBE0/aug-cc-pVTZ level of theory
| Entry | ∇2 |
|
|
| |
|---|---|---|---|---|---|
| N13–H7 | 5a | 0.1554 | 0.0154 | −0.0687 | −21.55 |
| 5b | 0.1557 | 0.0176 | −0.0655 | −20.55 | |
| 5c | 0.1527 | 0.0182 | −0.0658 | −20.65 | |
| N13–H7 | 5d | 0.1469 | 0.0133 | −0.0773 | −24.25 |
| 5e | 0.1506 | 0.0154 | −0.0732 | −22.97 | |
| 5f | 0.1452 | 0.0152 | −0.0756 | −23.72 | |
| O7–H6 | 5d | 0.0819 | 2.0981 | −0.0186 | −5.84 |
| 5e | 0.0821 | 2.1585 | −0.0186 | −5.84 | |
| 5f | 0.0821 | 4.1850 | −0.0184 | −5.77 |
Fig. 4Isosurfaces of the frontier molecular orbitals with isovalue of 0.0275 a.u. of the compounds 5a–5f.
Calculated maximum absorption wavelengths λmax,calc (nm), oscillator strengths (f), excitation energy (Eexcit, eV), % of contribution, assignment, and experimental λmax,exp (nm) of 4a, 4b, and 5a–5f compounds calculated at PBE0/aug-cc-pVTZ level of theory
| Compound |
|
|
| % major contribution | Assignment |
|
|---|---|---|---|---|---|---|
| 4a | 300.73 | 0.4392 | 4.1227 | HOMO → LUMO (100%) | π → π* | 325 |
| 5a | 310.79 | 0.3997 | 3.9893 | HOMO → LUMO (97%) | π → π* | 321 |
| 5b | 310.06 | 0.4010 | 3.9987 | HOMO → LUMO (100%) | π → π* | 320 |
| 5c | 310.06 | 0.4017 | 3.9987 | HOMO → LUMO (98%) | π → π* | 316 |
| 4b | 322.38 | 0.3282 | 3.8458 | HOMO → LUMO (99%) | π → π* | — |
| 5d | 329.54 | 0.3441 | 3.7623 | HOMO → LUMO (100%) | π → π* | 346 |
| 5e | 329.01 | 0.3378 | 3.7684 | HOMO → LUMO (97%) | π → π* | 346 |
| 5f | 329.48 | 0.3407 | 3.7631 | HOMO → LUMO (99%) | π → π* | 346 |
E exc = 319–323 nm in different organic solvents in ref. 32.
In ref. 23.
Fig. 5Isosurfaces of the electronic density difference between the ground state and the excited state with isovalues of −0.0001 a.u. (yellow) and +0.0001 a.u. (blue) of the compounds 5a–5f.
Results of antiproliferative activity by MTT essay of selected compoundsa
| Compound | Concentration (μM) | ||||||
|---|---|---|---|---|---|---|---|
| 0.001 | 0.01 | 0.1 | 1 | 10 | 100 | IC50 (μM) | |
| 4a | 136.3 ± 10.86 | 129.7 ± 19.16 | 140.1 ± 13.74 | 133.6 ± 12.88 | 131.9 ± 14.48 | 135.7 ± 22.93 | UNDETM |
| 4b | 103 ± 6.55 | 117.6 ± 1.72 | 116.1 ± 8.51 | 113.8 ± 12.44 | 111.5 ± 1.76 | 67.78 ± 7.69 | UNDETM |
| 5a | 90.62 ± 2.6 | 91.15 ± 1.69 | 98.47 ± 5.16 | 121.3 ± 5.55 | 112 ± 9.61 | 88.57 ± 4.99 | UNDETM |
| 5b | 111.5 ± 16.39 | 118.1 ± 13.77 | 106.8 ± 16.7 | 98.02 ± 15.72 | 85.78 ± 19.24 | 80.32 ± 12.73 | 1281 ± 82.6 |
| 5c | 95.61 ± 4.57 | 101.3 ± 2.67 | 109.3 ± 4.67 | 104.9 ± 9.14 | 89.81 ± 6.74 | 77.52 ± 5.55 | 582.1 ± 3.57 |
| 5d | 99.79 ± 2.58 | 109.3 ± 7.72 | 104.1 ± 7.47 | 107.7 ± 8.64 | 76.93 ± 8.92 | 32.47 ± 3.24*** | 43.76 ± 1.29 |
| 5e | 95.15 ± 9.10 | 93.72 ± 11.91 | 104 ± 6.52 | 101.2 ± 8.33 | 111.6 ± 10.07 | 56.18 ± 5.85* | UNDETM |
| 5f | 85.85 ± 11.35 | 83.03 ± 6.92 | 88.85 ± 10.9 | 108.1 ± 7.16 | 86.1 ± 12.1 | 35.87 ± 10.88** | 58.44 ± 1.43 |
UNDETM: undetermined. Absorbance values were normalized as proliferation percentage of control (mean ± SEM), data from three independent experiments. Asterisks represent statistical significance compared to control (0 mM). *p < 0.05, **p < 0.01, ***p < 0.001.
Fig. 6Antiproliferative effect of Mannich bases in HeLa cancer cell line (A–F).